Kerrisdale Advisers LLC Sells 265 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kerrisdale Advisers LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,852 shares of the healthcare conglomerate’s stock after selling 265 shares during the period. Kerrisdale Advisers LLC’s holdings in UnitedHealth Group were worth $937,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of UNH. Sugarloaf Wealth Management LLC boosted its holdings in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after acquiring an additional 1,193 shares in the last quarter. Signal Advisors Wealth LLC boosted its stake in shares of UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares in the last quarter. Waycross Partners LLC raised its stake in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after buying an additional 658 shares in the last quarter. Czech National Bank boosted its position in UnitedHealth Group by 6.1% during the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock valued at $100,937,000 after acquiring an additional 11,426 shares in the last quarter. Finally, Lmcg Investments LLC raised its position in shares of UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock worth $19,210,000 after acquiring an additional 4,022 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on UNH shares. Mizuho upped their price target on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Finally, Truist Financial lowered their price objective on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research note on Monday. Three research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $604.67.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH stock opened at $428.25 on Thursday. The company has a market capitalization of $391.73 billion, a price-to-earnings ratio of 27.63, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company’s fifty day moving average price is $506.92 and its 200-day moving average price is $537.23. UnitedHealth Group Incorporated has a one year low of $417.12 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.96%. UnitedHealth Group’s payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.